The bacterial species, Bifidobacterium pseudolongum, Lactobacillus johnsonii and Olsenella species have demonstrated enhanced efficacy of ICIs in four different murine cancer models through the production of inosine, which through interaction with adenosine A2A receptor induced anti-tumor CD4+T cell activation [96]. This evidence concerns the gene CD4 and neoplasm.